Brief: BB Biotech FY Net Gain At CHF 677 Mln
Feb 21 (Reuters) - BB BIOTECH AG BION.S :
* CONSOLIDATED AND AUDITED FULL YEAR 2019 DATA SHOWED A NET
GAIN
OF CHF 677 MN COMPARED TO A NET LOSS OF CHF 471 MN FOR 2018
* BIOTECH WILL PROPOSE AN ORDINARY DIVIDEND OF CHF 3.40 PER
SHARE
Source text for Eikon: ID:nEQ2l2j6Sa
Further company coverage: BION.S
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))
Recent news on Bb Biotech AG
See all newsBrief: BB Biotech Reports Net Profit Of CHF 451 Mln In Q2 2026
Switzerland's BB Biotech Q1 net loss narrows amid portfolio rotation
Brief: BB Biotech Reports Q1 Net Loss Of CHF 21 Million
Brief: BB BIOTECH Q1 Net Income CHF -21 Million
Brief: BB Biotech Says All Proposals Of Board Of Directors Approved At AGM